Literature DB >> 7351879

Arterial-venous differences of plasma catecholamines in man.

J B Halter, A E Pflug, A G Tolas.   

Abstract

To investigate the relationship between forearm venous levels of catecholamines and systemic levels, simultaneous arterial and forearm vein blood samples were obtained from 14 subjects undergoing elective dental procedures and assayed with a sensitive and specific radioenzymatic assay. Baseline venous levels of norepinephrine were greater than arterial levels (305 +/- 30 pg/ml versus 221 +/- 18; +/- SEM, p less than .005). Conversely, arterial epinephrine levels were higher than venous (132 +/- 17 pg/ml versus 80 +/- 10; p less than .005). There was a significant relationship between arterial and venous levels of both norepinephrine (r = .77, p less than .01) and epinephrine (r = .67, p less than .01). The arterial-venous epinephrine difference increased from the baseline value of 44 +/- 14 pg/ml to 108 +/- 16 (p less than .005) by 3 min after subcutaneous injection of epinephrine (18 microgram), but the arterial-venous difference returned to 65 +/- 24 by 5 min after injection (p = NS versus baseline). These findings indicate that under the conditions of this study, forearm tissues produced more norepinephrine than they removed, but removed more epinephrine than they produced. Baseline venous and arterial levels were related; when epinephrine production was augmented, there was a short time lag for the venous epinephrine increase.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7351879     DOI: 10.1016/0026-0495(80)90090-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

Review 1.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

2.  Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Jose Martinez; Horacio Kaufmann
Journal:  Neurology       Date:  2018-09-19       Impact factor: 9.910

3.  Effect of sympathomimetics on gastrin secretion from antral G cells in culture.

Authors:  A M Buchan
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Proceedings of the joint meeting of the Scandinavian and British Pharmacological Societies. Stockholm--Sweden. 5th and 6th July, 1982.

Authors: 
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

5.  Epinephrine facilitates neurogenic vasoconstriction in humans.

Authors:  J S Floras; P E Aylward; R G Victor; A L Mark; F M Abboud
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

6.  The influence of propranolol on the cardiovascular effects and plasma clearance of epinephrine.

Authors:  T Ichinohe; O Igarashi; Y Kaneko
Journal:  Anesth Prog       Date:  1991 Nov-Dec

7.  High concentrations of catecholamines in human hypothalamic-hypophysial blood.

Authors:  R Paradisi; G Frank; G Grossi; S Venturoli; E Porcu; M Capelli; E Galassi; C Flamigni
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

8.  Plasma l-[3H]norepinephrine, d-[14C]norepinephrine, and d,l-[3H]isoproterenol kinetics in essential hypertension.

Authors:  D S Goldstein; D Horwitz; H R Keiser; R J Polinsky; I J Kopin
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  Effects of lidocaine with epinephrine on fear related arousal among dental phobics.

Authors:  L Fiset; D Ramsay; P Milgrom; P Weinstein
Journal:  Anesth Prog       Date:  1986 Sep-Oct

10.  Increased arterial and venous plasma noradrenaline levels in patients with primary hypothyroidism during hypothyroid as compared to euthyroid state.

Authors:  P Manhem; M Bramnert; B Hallengren; H Lecerof; R Werner
Journal:  J Endocrinol Invest       Date:  1992-11       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.